These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2753061)

  • 1. Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
    Hurteloup P; Chollet P; Roche H; Chevallier B; Cappelaere P; Van Glabbece M; Hayat M; Armand JP
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):995-6. PubMed ID: 2753061
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma.
    Kish JA; Ensley JF; al-Sarraf M
    Am J Clin Oncol; 1990 Feb; 13(1):17-8. PubMed ID: 2305717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
    Braich TA; Salmon SE; Robertone A; Alberts DS; Jones SE; Miller TP; Garewal HS
    Invest New Drugs; 1986; 4(3):269-74. PubMed ID: 3818231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 5. 4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Bono AV; Kaye SB; Splinter TA; Calciati A; Fosså SD; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1531-2. PubMed ID: 3595678
    [No Abstract]   [Full Text] [Related]  

  • 6. Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group.
    van Oosterom AT; Aapro MS; Carnino F; van der Burg ME; Pecorelli S; Rotmensz N; Dalesio O; Vermorken JB
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1379-80. PubMed ID: 3181261
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.
    Carlson RW; Williams RD; Billingham ME; Kohler M; Torti FM
    Cancer Treat Rep; 1987; 71(7-8):767-8. PubMed ID: 3607787
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.
    Alberts DS; Mason-Liddil N; Stock-Novack D; O'Toole RV; Abbott TM; Salmon SE
    Am J Clin Oncol; 1992 Apr; 15(2):146-9. PubMed ID: 1553903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.
    Motzer R; Scher H; Bajorin D; Sternberg C; Bosl GJ
    Invest New Drugs; 1990 Nov; 8(4):391-2. PubMed ID: 2084073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
    Ringenberg QS; Propert KJ; Muss HB; Weiss RB; Schilsky RL; Modeas C; Perry MC; Norton L; Green M
    Invest New Drugs; 1990 May; 8(2):221-6. PubMed ID: 2166722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
    Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.
    Green MD; Speyer JL; Wernz JC; Colombo N; Beller U; Muggia FM; Beckman EM
    Invest New Drugs; 1990 Aug; 8(3):333-6. PubMed ID: 2272774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
    Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
    Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.
    Vaughn CB; Salmon SE; Fleming TR
    Invest New Drugs; 1990 Feb; 8(1):81-5. PubMed ID: 2188929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy. A Southwest Oncology Group study.
    Green JB; Green S; O'Toole RV; Alberts DS; Nahhas WA; Wallace DL
    Invest New Drugs; 1991 May; 9(2):191-3. PubMed ID: 1874602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esorubicin (4'-deoxydoxorubicin, NSC 267469) in advanced breast cancer. A phase II study of the CALGB.
    Muss HB; Van Echo D; Korzun AH; Henderson IC; Campbell T; Vogelzang NJ; Rice MA; Wood W
    Am J Clin Oncol; 1990 Jun; 13(3):233-7. PubMed ID: 2346128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).
    Hochster H; Hunt M; Green M; Parkinson D; Smith T
    Invest New Drugs; 1990 Aug; 8(3):329-32. PubMed ID: 2272773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma.
    Evans WK; Shepherd FA; Blackstein ME; Osoba D; Taylor D
    Cancer Treat Rep; 1985 Jun; 69(6):727-8. PubMed ID: 4016779
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of deoxydoxorubicin in patients with advanced liver cancer.
    Perry DJ; Van Echo DA; Mick R
    Cancer Treat Rep; 1987 Nov; 71(11):1117-8. PubMed ID: 3119209
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.